BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 200845)

  • 1. Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis.
    Tursz T; Fridman WH; Senik A; Tsapis A; Fellous M
    Nature; 1977 Oct; 269(5631):806-8. PubMed ID: 200845
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E; Masucci MG
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M
    J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis.
    Sethi KK; Stroehmann I; Brandis H
    Nature; 1980 Aug; 286(5774):718-20. PubMed ID: 6251371
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
    Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L
    J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytotoxicity of human T-lymphocytes sensitized by Epstein-Barr virus. Role of HLA antigens at the surface of target cells infected by the virus].
    Tursz T; Fridman WH; Tsapis A; Senik A; Fellous M
    C R Acad Hebd Seances Acad Sci D; 1977 May; 284(20):2063-6. PubMed ID: 196780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Epstein-Barr virus and infectious mononucleosis.
    Royston I
    Lancet; 1973 Nov; 2(7838):1152. PubMed ID: 4128043
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response.
    Wallace LE; Rickinson AB; Rowe M; Moss DJ; Allen DJ; Epstein MA
    Cell Immunol; 1982 Feb; 67(1):129-40. PubMed ID: 6176332
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    Bibl Haematol; 1975 Oct; (43):278-80. PubMed ID: 183684
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G; Rickinson AB
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
    J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
    Tomkinson BE; Maziarz R; Sullivan JL
    J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ; Wallace LE; Rickinson AB; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients.
    Bakacs T; Svedmyr E; Klein E
    Cancer Lett; 1978 Apr; 4(4):185-9. PubMed ID: 206347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.
    Misko IS; Moss DJ; Pope JH
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4247-50. PubMed ID: 6254017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants.
    Wallace LE; Moss DJ; Rickinson AB; McMichael AJ; Epstein MA
    Eur J Immunol; 1981 Sep; 11(9):694-9. PubMed ID: 6271557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of cell-mediated immunity during acute infectious mononucleosis.
    Mangi RJ; Niederman JC; Kelleher JE; Dwyer JM; Evans AS; Kantor FS
    N Engl J Med; 1974 Nov; 291(22):1149-53. PubMed ID: 4370990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.